Minimally Invasive Management of Upper Tract Malignancies: Renal Cell and Transitional Cell Carcinoma

Box, Geoffrey N.; Lehman, Daniel S.; Landman, Jaime; Clayman, Ralph V.

doi:10.1016/j.ucl.2008.05.010

Cited by 8 publications

(5 citation statements)

References 100 publications

(114 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our ENDO complication rate was similar to those summarized in the recent review by Moore et al 13 Our laparoscopic NUx complication rate was comparable to that in the recent review by Box et al 14 The lower complication rate and the outpatient nature of ureteroscopy make ENDO preferred over NUx in many patients. In contrast, some patients are dissuaded by the high procedural burden of ENDO and elect immediate NUx.…”

Section: Discussionsupporting

confidence: 86%

Long-Term Outcomes of Nephroureterectomy Versus Endoscopic Management for Upper Tract Urothelial Carcinoma

et al. 2010

View full text Add to dashboard Cite

When technically feasible and in select patients, endoscopic management provides cancer related and overall survival equivalent to that of nephroureterectomy in patients with low grade upper tract urothelial carcinoma at the cost of frequent re-treatments in many patients. Nephroureterectomy is standard treatment for high grade cancer when there is a normal contralateral kidney but endoscopy should be considered when there are imperative indications for nephron sparing.

show abstract

Section: Discussionsupporting

confidence: 86%

Long-Term Outcomes of Nephroureterectomy Versus Endoscopic Management for Upper Tract Urothelial Carcinoma

et al. 2010

View full text Add to dashboard Cite

show abstract

“…[3233] Comparison of the efficacy of ureteroscopic versus percutaneous data is difficult due to differing patient populations (including tumor size, stage and grade) and differences in measuring outcome. Table 4 and 5 display results from the major contemporary series of ureteroscopic and percutaneous management, respectively.…”

Section: Resultsmentioning

confidence: 99%

Endoscopic management of upper tract transitional cell carcinoma

et al. 2010

View full text Add to dashboard Cite

Upper urinary tract transitional cell carcinoma (TCC) accounts for up to 10% of cases of neoplasm of the upper urinary tract. The “gold standard” management of upper tract TCC is nephroureterectomy. Technological innovations, miniaturisations and increased availability of energy sources such as Holmium laser fibers have improved the armamentarium of endoscopic management of upper tract TCC. Endoscopic management of upper tract TCC includes the percutaneous (antegrade) and retrograde approaches. Modern flexible ureterorenoscopy allows retrograde approach to small (<1.5cm), low grade and noninvasive tumors, which is inaccessible to standard rigid ureteroscopes without breaching the urothelial barrier. In patients with large tumors or in whom retrograde access is difficult, the percutaneous approach to the renal pelvis, although more invasive, provides an alternative access and control. Both retrograde and percutaneous approaches allow instillation of various chemotherapeutic agents. Careful selection of patients is the key point in the successful endoscopic management of upper tract TCC. Patient selection is based on tumor size, grade and multifocality and other patient factors such as comorbidities, single kidney, post kidney transplant and patient choice. Both motivation and compliance of patients are needed for long-term successes. However, until large randomized trials with long term follow-up are available, endoscopic management of upper tract TCC should be reserved for only selected group of patients. This review summarizes the current techniques, indications, contraindications and outcomes of endoscopic management of UTTCC and the key published data.

show abstract

“…In upper-tract TCC, endoscopic surgery could be applied to patients with a solitary kidney, bilateral disease, high surgical risk, or chronic renal insufficiency with incidental discovery of the tumor. [12] In our cases, the percutaneous surgery was taken into consideration because of the risk of dialysis and the non-invasive nature of tumor (TCC of T 1 G 1 ) in collecting system revealed by CT scan.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous nephroscopic resection of pyelocaliceal transitional cell carcinoma in solitary kidney

Yang

Sun

2014

Urol Ann

View full text Add to dashboard Cite

show abstract

Minimally Invasive Management of Upper Tract Malignancies: Renal Cell and Transitional Cell Carcinoma

Cited by 8 publications

References 100 publications

Long-Term Outcomes of Nephroureterectomy Versus Endoscopic Management for Upper Tract Urothelial Carcinoma

Long-Term Outcomes of Nephroureterectomy Versus Endoscopic Management for Upper Tract Urothelial Carcinoma

Endoscopic management of upper tract transitional cell carcinoma

Percutaneous nephroscopic resection of pyelocaliceal transitional cell carcinoma in solitary kidney

Contact Info

Product

Resources

About